HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Expression of EMMPRIN in adenoid cystic carcinoma of salivary glands: correlation with tumor progression and patients' prognosis.

Abstract
Extracellular matrix metalloproteinase inducer (EMMPRIN) plays a critical role in the progression of malignancies by stimulating expression of metalloproteinases (MMPs) and vascular endothelial growth factor (VEGF) in stromal cells. However, the expression of EMMPRIN in adenoid cystic carcinoma (ACC) of salivary glands, and its correlation with patients' prognosis have never been investigated thus far. In the present study, the expression of EMMPRIN was examined in 72 ACCs and 20 normal salivary gland tissues by immunohistochemistry. The expression of MMP-2, MMP-9, VEGF, Ki-67 index, and microvessel density (MVD) labeled by CD31 were also assessed by immunohistochemistry in ACCs. The positivity of EMMPRIN in ACCs was 62.5%, which was significantly higher than that in normal salivary gland tissues (P<0.01). EMMPRIN expression was positively correlated with tumor size, histotypes, clinical stage, perineural invasion, vascular invasion, metastasis, expression of MMP-2, MMP-9, VEGF, Ki-67 index, and MVD (P<0.05), but not with gender, age, tumor site or recurrence (P>0.05). Multivariate analysis showed that EMMPRIN expression, Ki-67 index, and solid histotype had an independent prognostic effect on overall survival (P<0.05). According to our findings, EMMPRIN might actively be involved in the growth, angiogenesis, invasion and metastasis of ACCs. Measurement of EMMPRIN may be helpful in predicting patients' prognosis and understanding the malignant behaviors of ACCs.
AuthorsXinjie Yang, Jingyao Dai, Tao Li, Pu Zhang, Qin Ma, Yuan Li, Jun Zhou, Delin Lei
JournalOral oncology (Oral Oncol) Vol. 46 Issue 10 Pg. 755-60 (Oct 2010) ISSN: 1879-0593 [Electronic] England
PMID20850374 (Publication Type: Journal Article)
CopyrightCrown Copyright © 2010. Published by Elsevier Ltd. All rights reserved.
Chemical References
  • Ki-67 Antigen
  • Neoplasm Proteins
  • Vascular Endothelial Growth Factor A
  • Basigin
  • Matrix Metalloproteinase 2
  • Matrix Metalloproteinase 9
Topics
  • Adult
  • Basigin (metabolism)
  • Carcinoma, Adenoid Cystic (metabolism, pathology)
  • Disease Progression
  • Female
  • Humans
  • Ki-67 Antigen (metabolism)
  • Male
  • Matrix Metalloproteinase 2 (metabolism)
  • Matrix Metalloproteinase 9 (metabolism)
  • Middle Aged
  • Neoplasm Proteins (metabolism)
  • Neovascularization, Pathologic (metabolism, pathology)
  • Prognosis
  • Salivary Gland Neoplasms (metabolism, pathology)
  • Tumor Burden
  • Vascular Endothelial Growth Factor A (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: